Hangzhou Tigermed Consulting Co Ltd (3347.HK)
Company Info
ISIN | CNE1000040M1 |
---|---|
Sector | Healthcare |
Industry | Diagnostics & Research |
Highlights
Market Cap | HK$42.65B |
---|---|
EPS | HK$2.37 |
PE Ratio | 10.37 |
Revenue (TTM) | HK$7.33B |
Gross Profit (TTM) | HK$2.81B |
EBITDA (TTM) | HK$1.91B |
Year Range | HK$22.10 - HK$86.33 |
Target Price | HK$68.41 |
Share Price Chart
Loading data...
Compare to other instruments
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Hangzhou Tigermed Consulting Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Hangzhou Tigermed Consulting Co Ltd had a return of -16.27% year-to-date (YTD) and -62.01% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -16.27% | 10.16% |
1 month | 6.67% | 3.47% |
6 months | -32.80% | 22.20% |
1 year | -62.01% | 30.45% |
5 years (annualized) | N/A | 13.16% |
10 years (annualized) | N/A | 10.89% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -30.83% | 11.45% | ||||||||||
2023 | -15.18% | -3.86% | 6.93% | -6.26% | -14.20% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for Hangzhou Tigermed Consulting Co Ltd (3347.HK) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
Hangzhou Tigermed Consulting Co Ltd | -1.06 | ||||
S&P 500 | 2.79 |
Dividends
Dividend History
Hangzhou Tigermed Consulting Co Ltd granted a 2.08% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.62 per share.
Period | TTM | 2023 | 2022 | 2021 |
---|---|---|---|---|
Dividend | HK$0.62 | HK$0.62 | HK$0.58 | HK$0.36 |
Dividend yield | 2.08% | 1.74% | 0.64% | 0.37% |
Monthly Dividends
The table displays the monthly dividend distributions for Hangzhou Tigermed Consulting Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | HK$0.00 | HK$0.00 | ||||||||||
2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.62 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.58 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
2021 | HK$0.36 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Hangzhou Tigermed Consulting Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Hangzhou Tigermed Consulting Co Ltd was 88.05%, occurring on Feb 5, 2024. The portfolio has not yet recovered.
The current Hangzhou Tigermed Consulting Co Ltd drawdown is 84.88%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-88.05% | Jan 6, 2021 | 760 | Feb 5, 2024 | — | — | — |
-13.95% | Sep 1, 2020 | 6 | Sep 8, 2020 | 27 | Oct 20, 2020 | 33 |
-11.82% | Nov 18, 2020 | 9 | Nov 30, 2020 | 4 | Dec 4, 2020 | 13 |
-6.58% | Nov 10, 2020 | 2 | Nov 11, 2020 | 2 | Nov 13, 2020 | 4 |
-3.8% | Aug 10, 2020 | 3 | Aug 12, 2020 | 8 | Aug 24, 2020 | 11 |
Volatility
Volatility Chart
The current Hangzhou Tigermed Consulting Co Ltd volatility is 26.45%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |